CEL-SCI Corp. Daily Stock Analysis

Daily Stock Analysis, CVM, CEL-SCI Corp, priceseries

CEL-SCI Corp. Daily Stock Analysis
Stock Information
Open
5.04
Close
4.91
High
5.13
Low
4.78
Previous Close
4.96
Daily Price Gain
-0.05
YTD High
7.73
YTD High Date
Jan 4, 2022
YTD Low
4.78
YTD Low Date
Mar 7, 2022
YTD Price Change
-2.79
YTD Gain
-36.23%
52 Week High
27.86
52 Week High Date
Apr 22, 2021
52 Week Low
4.78
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-13.15
52 Week Gain
-72.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 5. 2017
2.04
Jan 18. 2017
2.97
8 Trading Days
45.51%
Link
LONG
Feb 9. 2017
3.06
Feb 14. 2017
3.23
3 Trading Days
5.49%
Link
LONG
Aug 11. 2017
2.31
Aug 18. 2017
2.44
5 Trading Days
5.65%
Link
LONG
Jan 22. 2018
2.20
Jan 25. 2018
2.35
3 Trading Days
6.59%
Link
LONG
Apr 10. 2018
1.64
May 15. 2018
2.64
25 Trading Days
61.21%
Link
LONG
Aug 17. 2018
1.18
Sep 13. 2018
3.09
18 Trading Days
161.48%
Link
LONG
Mar 28. 2019
3.20
Apr 30. 2019
6.41
22 Trading Days
100.38%
Link
LONG
Jun 7. 2019
4.69
Jul 10. 2019
8.19
22 Trading Days
74.55%
Link
LONG
Sep 12. 2019
7.64
Oct 2. 2019
8.82
14 Trading Days
15.44%
Link
LONG
Nov 13. 2019
7.12
Nov 25. 2019
7.51
8 Trading Days
5.43%
Link
LONG
Dec 16. 2019
7.93
Dec 26. 2019
8.51
7 Trading Days
7.28%
Link
LONG
Jan 15. 2020
9.10
Jan 31. 2020
12.29
11 Trading Days
35.04%
Link
LONG
Mar 6. 2020
13.75
Mar 9. 2020
14.79
1 Trading Days
7.60%
Link
LONG
Apr 21. 2020
11.43
May 4. 2020
14.23
9 Trading Days
24.52%
Link
LONG
Oct 1. 2020
13.41
Oct 19. 2020
15.18
12 Trading Days
13.20%
Link
LONG
Jan 27. 2021
25.00
Jan 28. 2021
30.00
1 Trading Days
20.00%
Link
LONG
Apr 20. 2021
18.71
May 3. 2021
22.51
9 Trading Days
20.33%
Link
LONG
Jun 23. 2021
22.81
Jun 28. 2021
25.05
3 Trading Days
9.80%
Link
LONG
Aug 2. 2021
8.15
Sep 9. 2021
10.90
27 Trading Days
33.70%
Link
Company Information
Stock Symbol
CVM
Exchange
NYSE MKT
Company URL
http://www.cel-sci.com
Company Phone
7035069460
CEO
Geert R. Kersten
Headquarters
Virginia
Business Address
8229 BOONE BLVD ., SUITE 802, VIENNA, VA 22182
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000725363
About

CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases. The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against advanced primary head and neck cancer. It is also developing its pre-clinical Ligand Epitope Antigen Presentation System technology for the potential treatment of pandemic influenza in hospitalized patients and as a potential vaccine for the treatment of rheumatoid arthritis. CEL-SCI was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Description

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company's Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading